Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 62.52
+0.48 (0.77%)
Aug 15, 2025, 2:45 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 37.44 billion as of August 15, 2025. Its market cap has increased by 37.95% in one year.
Market Cap
37.44B
Enterprise Value
35.20B
Revenue
3.80B
Ranking
n/a
PE Ratio
40.37
Stock Price
62.52
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 37.44B, an increase of 2.36%. That is a compound annual growth rate of 0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 37.44B | 42.17% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 419.23B |
| WuXi AppTec | 287.97B |
| Shenzhen Mindray Bio-Medical Electronics | 282.32B |
| Sichuan Biokin Pharmaceutical | 126.19B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.83B |
| Aier Eye Hospital Group | 120.01B |
| Shanghai United Imaging Healthcare | 104.90B |
| Yunnan Baiyao Group Co.,Ltd | 99.70B |